ASTH
Astrana Health Inc
35.90$
+2.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1.4% | +14.5% | +20.3% | -1.6% | +39.0% | -6.7% | +5.5% | +46.0% | -0.6% | +1.5% | +0.8% | – | |
| – | +14.0% | +6.8% | +25.3% | -3.6% | +48.6% | -8.8% | +5.1% | +51.6% | -0.3% | +0.3% | -0.7% | – | |
| – | -46.5% | +76.7% | -4.1% | +11.3% | -14.3% | +13.2% | +9.3% | +4.7% | -3.6% | +14.8% | +15.2% | – | |
| – | +29.0% | +2.0% | -7.2% | +5.1% | +10.1% | +5.4% | +15.6% | +123.0% | -91.6% | +548.4% | -12.3% | – | |
| – | +27.1% | -9.6% | -7.2% | +25.3% | +38.2% | -18.5% | +13.6% | +8.3% | -3.4% | +2.5% | +12.9% | – | |
| – | -109.9% | – | -0.2% | -5.5% | -97.5% | +2,758.8% | -1.2% | -5.6% | -4.2% | +55.1% | +20.3% | – | |
| – | +43.5% | +39.9% | +13.2% | +3.1% | -8.9% | -9.4% | +1.0% | +140.0% | -1.1% | -8.1% | -0.6% | – | |
| – | -97.6% | +2,497.8% | +32.9% | -15.9% | -107.1% | – | +75.2% | -66.3% | +32.4% | +162.6% | +38.1% | – | |
| – | -89.9% | +601.6% | +40.5% | -21.9% | -24.9% | -42.5% | +95.4% | -30.5% | -79.5% | +596.8% | +33.1% | – | |
| – | -44.0% | +20.1% | +29.2% | -16.1% | -143.2% | – | +40.8% | -96.0% | +1,508.3% | +140.6% | +36.7% | – | |
| – | -75.6% | +226.1% | +30.6% | -10.4% | -66.7% | +66.2% | +30.9% | +25.3% | +6.3% | +23.8% | -15.8% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.